Disaster If Covid Vaccines Administered To Children Without Proper Research: Court

Pharmaceutical major Zydus Cadila's COVID-19 vaccine may be available in the near future for children in the age group of 12 to 18 years, the Centre in an affidavit told the Delhi High Court on Friday.

Disaster If Covid Vaccines Administered To Children Without Proper Research: Court

Delhi High Court said if vaccines are administered to children without proper research may be a disaster.

New Delhi:

The Delhi High Court on Friday said that if COVID-19 vaccines are administered to children without proper research may be a disaster while objecting to the submission of the petitioner seeking research on vaccines for children in a time-bound manner.

A division bench of Chief Justice D N Patel and Justice Jyoti Singh said, "It would be a disaster if vaccines are administered on children without proper research."

Appearing for the petitioner, advocate Kailash Vasudev argued that there shall be a specific timeline as to when the vaccine trials for children would conclude.

The court warned that it would dispose of the matter if the petitioner makes such kinds of submissions and said that there cannot be a timeline for the research.

Pharmaceutical major Zydus Cadila's COVID-19 vaccine may be available in the near future for children in the age group of 12 to 18 years, the Centre in an affidavit told the Delhi High Court on Friday.

Zydus Cadila has concluded its trial for children between the age group of 12 to 18 and is subject to statutory permissions, the Centre added.

The Ahmedabad-based pharmaceutical firm had on July 1, requested emergency use approval for ZyCoV-D, its three-dose COVID shot - the world's first Plasmid DNA vaccine.

It will, however, be a few more days before the country's drug regulator Drugs Controller General of India (DCGI) gives it emergency use authorisation, sources told ANI on Monday.

The affidavit further submitted that vaccination is the Centre's topmost priority and all efforts are being made to achieve 100 per cent vaccination in the shortest time possible, keeping the availability of vaccine doses in mind.

It further submitted that on May 12, 2021, the Drug Controller General of India permitted Bharat Biotech to conduct clinical trials on healthy volunteers between 2 to 18 years of age, for its vaccine - Covaxin.

The affidavit was filed in the Delhi High Court by the Union Health Ministry on a plea filed by a minor, Tia Gupta, seeking immediate vaccination of minors between 12 to 17 years.